<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36917977</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4199</ISSN><JournalIssue CitedMedium="Internet"><Volume>111</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration.</ArticleTitle><Pagination><StartPage>1222</StartPage><EndPage>1240.e9</EndPage><MedlinePgn>1222-1240.e9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2023.02.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-6273(23)00123-X</ELocationID><Abstract><AbstractText>Mitochondrial dysfunction and axon loss are hallmarks of neurologic diseases. Gasdermin (GSDM) proteins are executioner pore-forming molecules that mediate cell death, yet their roles in the central nervous system (CNS) are not well understood. Here, we find that one GSDM family member, GSDME, is expressed by both mouse and human neurons. GSDME plays a role in mitochondrial damage and axon loss. Mitochondrial neurotoxins induced caspase-dependent GSDME cleavage and rapid localization to mitochondria in axons, where GSDME promoted mitochondrial depolarization, trafficking defects, and neurite retraction. Frontotemporal dementia (FTD)/amyotrophic lateral sclerosis (ALS)-associated proteins TDP-43 and PR-50 induced GSDME-mediated damage to mitochondria and neurite loss. GSDME knockdown protected against neurite loss in ALS patient iPSC-derived motor neurons. Knockout of GSDME in SOD1<sup>G93A</sup> ALS mice prolonged survival, ameliorated motor dysfunction, rescued motor neuron loss, and reduced neuroinflammation. We&#xa0;identify GSDME as an executioner of neuronal mitochondrial dysfunction that may contribute to neurodegeneration.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neel</LastName><ForeName>Dylan V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basu</LastName><ForeName>Himanish</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunner</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergstresser</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giadone</LastName><ForeName>Richard M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Ave, Cambridge, MA 02138, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Haeji</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chou</LastName><ForeName>Vicky</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brody</LastName><ForeName>Eliza</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mass General Institute for Neurodegenerative Disease (MIND), Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watts</LastName><ForeName>Michelle E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Ave, Cambridge, MA 02138, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sean M. Healey &amp; AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Held</LastName><ForeName>Aaron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sean M. Healey &amp; AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wainger</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Sean M. Healey &amp; AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagier-Tourenne</LastName><ForeName>Clotilde</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Mass General Institute for Neurodegenerative Disease (MIND), Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Broad Institute of Harvard University and MIT, Cambridge, MA 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yong-Jie</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrucelli</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young-Pearse</LastName><ForeName>Tracy L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen-Plotkin</LastName><ForeName>Alice S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubin</LastName><ForeName>Lee L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Stem Cell and Regenerative Biology, Harvard University, 7 Divinity Ave, Cambridge, MA 02138, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Judy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: judy.lieberman@childrens.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Isaac M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Department of Immunology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: isaac_chiu@hms.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 AG079593</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI168005</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG055909</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK127257</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 NS053488</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA240955</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS115139</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG062418</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS122292</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000094524">Gasdermins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094524" MajorTopicYN="N">Gasdermins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">FTD</Keyword><Keyword MajorTopicYN="N">axon degeneration</Keyword><Keyword MajorTopicYN="N">cell death</Keyword><Keyword MajorTopicYN="N">gasdermins</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neuroimmunology</Keyword><Keyword MajorTopicYN="N">pyroptosis</Keyword></KeywordList><CoiStatement>Declaration of interests I.M.C. receives sponsored research support from Abbvie/Allergan Pharmaceuticals and is on the SAB for GSK and LIMM therapeutics. J.L. is a cofounder and SAB member of Ventus Therapeutics.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>19</Hour><Minute>41</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36917977</ArticleId><ArticleId IdType="mid">NIHMS1876895</ArticleId><ArticleId IdType="pmc">PMC10121894</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2023.02.019</ArticleId><ArticleId IdType="pii">S0896-6273(23)00123-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murali Mahadevan H, Hashemiaghdam A, Ashrafi G, and Harbauer AB (2021). Mitochondria in Neuronal Health: From Energy Metabolism to Parkinson&#x2019;s Disease. Adv Biol 2100663, 2100663. 10.1002/adbi.202100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adbi.202100663</ArticleId><ArticleId IdType="pubmed">34382382</ArticleId></ArticleIdList></Reference><Reference><Citation>Venderova K, and Park DS (2012). Programmed cell death in Parkinson&#x2019;s disease. Cold Spring Harb Perspect Med 2, 1&#x2013;23. 10.1101/cshperspect.a009365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a009365</ArticleId><ArticleId IdType="pmc">PMC3405826</ArticleId><ArticleId IdType="pubmed">22908196</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranov S. v., Baranova O. v., Yablonska S, Suofu Y, Vazquez AL, Kozai TDY, Tracy Cui X, Ferrando LM, Larkin TM, Tyurina YY, et al. (2019). Mitochondria modulate programmed neuritic retraction. Proc Natl Acad Sci U S A 116, 650&#x2013;659. 10.1073/pnas.1811021116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1811021116</ArticleId><ArticleId IdType="pmc">PMC6329959</ArticleId><ArticleId IdType="pubmed">30584104</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes L, Lebenkoff S, White K, Gerdts C, Hopkins K, Potter JE, Grossman D, Project PE, and Sciences R (2016). Releasing Syntaphilin Removes Stressed Mitochondria from Axons Independent of Mitophagy under Pathophysiological Conditions. Neuron 93, 292&#x2013;297. 10.1016/j.neuron.2017.04.004.Releasing.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.04.004.Releasing</ArticleId><ArticleId IdType="pmc">PMC5484086</ArticleId><ArticleId IdType="pubmed">28472658</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock FJ, and Tait SWG (2020). Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 21, 85&#x2013;100. 10.1038/s41580-019-0173-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0173-8</ArticleId><ArticleId IdType="pubmed">31636403</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, and Alnemri ES (2017). Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun 8, 1&#x2013;14. 10.1038/ncomms14128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14128</ArticleId><ArticleId IdType="pmc">PMC5216131</ArticleId><ArticleId IdType="pubmed">28045099</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, and Shao F (2017). Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99&#x2013;103. 10.1038/nature22393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22393</ArticleId><ArticleId IdType="pubmed">28459430</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F, and Shao F (2015). Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 10.1038/nature15514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15514</ArticleId><ArticleId IdType="pubmed">26375003</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, and Lieberman J (2016). Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153&#x2013;158. 10.1038/nature18629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18629</ArticleId><ArticleId IdType="pmc">PMC5539988</ArticleId><ArticleId IdType="pubmed">27383986</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayagaki N, Stowe IB, Lee BL, O&#x2019;Rourke K, Anderson K, Warming S, Cuellar T, Haley B, Roose-Girma M, Phung QT, et al. (2015). Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 10.1038/nature15541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15541</ArticleId><ArticleId IdType="pubmed">26375259</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vasconcelos NM, van Opdenbosch N, van Gorp H, Parthoens E, and Lamkanfi M (2019). Single-cell analysis of pyroptosis dynamics reveals conserved GSDMD-mediated subcellular events that precede plasma membrane rupture. Cell Death Differ 26, 146&#x2013;161. 10.1038/s41418-018-0106-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-018-0106-7</ArticleId><ArticleId IdType="pmc">PMC6294780</ArticleId><ArticleId IdType="pubmed">29666477</ArticleId></ArticleIdList></Reference><Reference><Citation>de Torre-Minguela C, G&#xf3;mez AI, Couillin I, and Pelegr&#xed;n P (2021). Gasdermins mediate cellular release of mitochondrial DNA during pyroptosis and apoptosis. FASEB Journal 35. 10.1096/fj.202100085R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202100085R</ArticleId><ArticleId IdType="pubmed">34233045</ArticleId></ArticleIdList></Reference><Reference><Citation>Weindel CG, Martinez EL, Zhao X, Mabry CJ, Bell SL, Vail KJ, Coleman AK, VanPortfliet JJ, Zhao B, Wagner AR, et al. (2022). Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis. Cell 185, 3214&#x2013;3231.e23. 10.1016/j.cell.2022.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.038</ArticleId><ArticleId IdType="pmc">PMC9531054</ArticleId><ArticleId IdType="pubmed">35907404</ArticleId></ArticleIdList></Reference><Reference><Citation>Orzalli MH, Prochera A, Payne L, Smith A, Garlick JA, and Kagan JC (2021). Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells. Immunity, 1&#x2013;16. 10.1016/j.immuni.2021.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.04.012</ArticleId><ArticleId IdType="pmc">PMC8594743</ArticleId><ArticleId IdType="pubmed">33979579</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan G, Huang C, Chen J, Chen B, and Zhi F (2021). Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn&#x2019;s disease by promoting intestinal inflammation. Cell Rep 35, 109265. 10.1016/j.celrep.2021.109265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109265</ArticleId><ArticleId IdType="pubmed">34133932</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia W, Li Y, Wu M, Jin Q, Wang Q, Li S, Huang S, Zhang A, Zhang Y, and Jia Z (2021). Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation. Cell Death Dis 12. 10.1038/s41419-021-03431-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03431-2</ArticleId><ArticleId IdType="pmc">PMC7862699</ArticleId><ArticleId IdType="pubmed">33542198</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai B, Liao C, He D, Chen J, Han J, Lu J, Qin K, Liang W, Wu X, Liu Z, et al. (2021). Gasdermin E mediates photoreceptor damage by all-trans-retinal in the mouse retina. Journal of Biological Chemistry, 101553. 10.1016/j.jbc.2021.101553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101553</ArticleId><ArticleId IdType="pmc">PMC8800116</ArticleId><ArticleId IdType="pubmed">34973334</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Li S, Qi J, Chen Z, Wu Y, Guo J, Wang K, Sun X, and Zheng J (2019). Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells. Cell Death Dis 10. 10.1038/s41419-019-1441-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1441-4</ArticleId><ArticleId IdType="pmc">PMC6389936</ArticleId><ArticleId IdType="pubmed">30804337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zhang Y, Xia S, Kong Q, Li S, Liu X, Junqueira C, Meza-Sosa KF, Mok TMY, Ansara J, et al. (2020). Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 579, 415&#x2013;420. 10.1038/s41586-020-2071-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2071-9</ArticleId><ArticleId IdType="pmc">PMC7123794</ArticleId><ArticleId IdType="pubmed">32188940</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, and Verhaagen J (2014). ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci. 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Chen L, Zhang S, He J, and Fan D (2021). Early Axonal Dysfunction of the Peripheral Nervous System Influences Disease Progression of ALS: Evidence From Clinical Neuroelectrophysiology. Front Neurol 12. 10.3389/fneur.2021.574919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.574919</ArticleId><ArticleId IdType="pmc">PMC7905229</ArticleId><ArticleId IdType="pubmed">33643181</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarz TL (2013). Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol 5. 10.1101/cshperspect.a011304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a011304</ArticleId><ArticleId IdType="pmc">PMC3660831</ArticleId><ArticleId IdType="pubmed">23732472</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J, and Xu Z (1998). Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1. The Journal of Neuroscience 18, 3241&#x2013;3250. 10.1523/JNEUROSCI.18-09-03241.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-09-03241.1998</ArticleId><ArticleId IdType="pmc">PMC6792665</ArticleId><ArticleId IdType="pubmed">9547233</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Lillo C, Jonsson PA, Velde C vande, Ward CM, Miller TM, Subramaniam JR, Rothstein JD, Marklund S, Andersen PM, et al. (2004). Toxicity of Familial ALS-Linked SOD1 Mutants from Selective Recruitment to Spinal Mitochondria. Neuron 43, 5&#x2013;17. 10.1016/j.neuron.2004.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.016</ArticleId><ArticleId IdType="pubmed">15233913</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken TE, Jorstad NL, Hu Q, Lake BB, Tian W, Kalmbach BE, Crow M, Hodge RD, Krienen FM, Sorensen SA, et al. (2021). Comparative cellular analysis of motor cortex in human, marmoset and mouse. Nature 598, 111&#x2013;119. 10.1038/s41586-021-03465-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03465-8</ArticleId><ArticleId IdType="pmc">PMC8494640</ArticleId><ArticleId IdType="pubmed">34616062</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Z, van Velthoven CTJ, Nguyen TN, Goldy J, Sedeno-Cortes AE, Baftizadeh F, Bertagnolli D, Casper T, Chiang M, Crichton K, et al. (2021). A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation. Cell 184, 3222&#x2013;3241.e26. 10.1016/J.CELL.2021.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2021.04.021</ArticleId><ArticleId IdType="pmc">PMC8195859</ArticleId><ArticleId IdType="pubmed">34004146</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaum N, Karkanias J, Neff NF, May AP, Quake SR, Wyss-Coray T, Darmanis S, Batson J, Botvinnik O, Chen MB, et al. (2018). Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature 562, 367&#x2013;372. 10.1038/s41586-018-0590-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0590-4</ArticleId><ArticleId IdType="pmc">PMC6642641</ArticleId><ArticleId IdType="pubmed">30283141</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CT, Bay&#x131;r H, and Kagan VE (2014). LC3 binds externalized cardiolipin on injured mitochondria to signal mitophagy in neurons: implications for Parkinson disease. Autophagy 10, 376&#x2013;378. 10.4161/auto.27191.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.27191</ArticleId><ArticleId IdType="pmc">PMC5396091</ArticleId><ArticleId IdType="pubmed">24351649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA, Tyurin VA, Yanamala N, Shrivastava IH, Mohammadyani D, et al. (2013). Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol 15, 1197&#x2013;1205. 10.1038/ncb2837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2837</ArticleId><ArticleId IdType="pmc">PMC3806088</ArticleId><ArticleId IdType="pubmed">24036476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagomarsino VN, Pearse R. v., Liu L, Hsieh Y-C, Fernandez MA, Vinton EA, Paull D, Felsky D, Tasaki S, Gaiteri C, et al. (2021). Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron 109, 3402&#x2013;3420.e9. 10.1016/j.neuron.2021.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2021.08.003</ArticleId><ArticleId IdType="pmc">PMC8571042</ArticleId><ArticleId IdType="pubmed">34473944</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Pak C, Han Y, Ahlenius H, Zhang Z, Chanda S, Marro S, Patzke C, Acuna C, Covy J, et al. (2013). Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells. Neuron 78, 785&#x2013;798. 10.1016/j.neuron.2013.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.05.029</ArticleId><ArticleId IdType="pmc">PMC3751803</ArticleId><ArticleId IdType="pubmed">23764284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemasters JJ, Qian T, Bradham CA, Brenner DA, Cascio WE, Trost LC, Nishimura Y, Nieminen A-L, and Herman B (1999). Mitochondrial Dysfunction in the Pathogenesis of Necrotic and Apoptotic Cell Death.</Citation><ArticleIdList><ArticleId IdType="pubmed">10665521</ArticleId></ArticleIdList></Reference><Reference><Citation>Maor-Nof M, Shipony Z, Lopez-Gonzalez R, Nakayama L, Zhang YJ, Couthouis J, Blum JA, Castruita PA, Linares GR, Ruan K, et al. (2021). p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). Cell 184, 689&#x2013;708.e20. 10.1016/j.cell.2020.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7886018</ArticleId><ArticleId IdType="pubmed">33482083</ArticleId></ArticleIdList></Reference><Reference><Citation>Ert&#xfc;rk A, Wang Y, and Sheng M (2014). Local pruning of dendrites and spines by caspase-3-dependent and proteasome-limited mechanisms. Journal of Neuroscience 34, 1672&#x2013;1688. 10.1523/JNEUROSCI.3121-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3121-13.2014</ArticleId><ArticleId IdType="pmc">PMC6827581</ArticleId><ArticleId IdType="pubmed">24478350</ArticleId></ArticleIdList></Reference><Reference><Citation>Medana IM, and Esiri MM (2003). Axonal damage: A key predictor of outcome in human CNS diseases. Brain 126, 515&#x2013;530. 10.1093/brain/awg061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awg061</ArticleId><ArticleId IdType="pubmed">12566274</ArticleId></ArticleIdList></Reference><Reference><Citation>Conforti L, Gilley J, and Coleman MP (2014). Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci 15, 394&#x2013;409. 10.1038/nrn3680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3680</ArticleId><ArticleId IdType="pubmed">24840802</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, Jiang S, Ma X, Jiang Z, da Rocha EL, et al. (2016). The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med 22, 869&#x2013;878. 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CH, Davidson S, Harapas CR, Hilton JB, Mlodzianoski MJ, Laohamonthonkul P, Louis C, Low RRJ, Moecking J, de Nardo D, et al. (2020). TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell 183, 636&#x2013;649.e18. 10.1016/j.cell.2020.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.020</ArticleId><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P, Deng J, Dong J, Liu J, Bigio EH, Mesulam M, Wang T, Sun L, Wang L, Lee AYL, et al. (2019). TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LR, Duan L, Bowen K, Kalab P, and Rothstein JD (2020). C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. Elife 9. 10.7554/eLife.51685.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.51685</ArticleId><ArticleId IdType="pmc">PMC7051184</ArticleId><ArticleId IdType="pubmed">32119645</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, and Taylor JP (2017). The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front Mol Neurosci 10. 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Krach F, Batra R, Wheeler EC, Vu AQ, Wang R, Hutt K, Rabin SJ, Baughn MW, Libby RT, Diaz-Garcia S, et al. (2018). Transcriptome&#x2013;pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol 136, 405&#x2013;423. 10.1007/s00401-018-1870-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1870-7</ArticleId><ArticleId IdType="pmc">PMC6215775</ArticleId><ArticleId IdType="pubmed">29881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Watts ME, and Rubin LL (2019). MAP4K4 Activation Mediates Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis. Cell Rep 26, 1143&#x2013;1156.e5. 10.1016/j.celrep.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.01.019</ArticleId><ArticleId IdType="pubmed">30699345</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng H-X, et al. (1994). Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation. Science (1979) 264, 1772&#x2013;1775. 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowling AC, Schulz JB, Brown RH, and Beal MF (1993). Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotrophic Lateral Sclerosis. J Neurochem 61, 2322&#x2013;2325. 10.1111/j.1471-4159.1993.tb07478.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1993.tb07478.x</ArticleId><ArticleId IdType="pubmed">8245985</ArticleId></ArticleIdList></Reference><Reference><Citation>Neel D. v., Basu H, Gunner G, and Chiu IM (2022). Catching a killer: Mechanisms of programmed cell death and immune activation in Amyotrophic Lateral Sclerosis. Immunol Rev 311, 130&#x2013;150. 10.1111/imr.13083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13083</ArticleId><ArticleId IdType="pmc">PMC9489610</ArticleId><ArticleId IdType="pubmed">35524757</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, Cunha C, Nascimento F, Ribeiro JA, Vaz AR, and Brites D (2019). Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model. Mol Neurobiol 56, 2137&#x2013;2158. 10.1007/s12035-018-1220-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1220-8</ArticleId><ArticleId IdType="pubmed">29995256</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLean M, Juranek J, Cuddapah S, L&#xf3;pez-D&#xed;ez R, Ruiz HH, Hu J, Frye L, Li H, Gugger PF, and Schmidt AM (2021). Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner. J Neuroinflammation 18, 139. 10.1186/s12974-021-02191-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02191-2</ArticleId><ArticleId IdType="pmc">PMC8207569</ArticleId><ArticleId IdType="pubmed">34130712</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadeas ST, Kraig SE, O&#x2019;Banion C, Lepore AC, and Maragakis NJ (2011). Astrocytes carrying the superoxide dismutase 1 (SOD1 G93A ) mutation induce wild-type motor neuron degeneration in vivo. Proceedings of the National Academy of Sciences 108, 17803&#x2013;17808. 10.1073/pnas.1103141108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1103141108</ArticleId><ArticleId IdType="pmc">PMC3203804</ArticleId><ArticleId IdType="pubmed">21969586</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P, Houseweart MK, Brown RH, and Cleveland DW (2000). Caspase-1 and &#x2212;3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences 97, 13901&#x2013;13906. 10.1073/pnas.240305897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.240305897</ArticleId><ArticleId IdType="pmc">PMC17673</ArticleId><ArticleId IdType="pubmed">11095709</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, and Alnemri ES (2019). Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun 10, 1&#x2013;17. 10.1038/s41467-019-09397-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09397-2</ArticleId><ArticleId IdType="pmc">PMC6459836</ArticleId><ArticleId IdType="pubmed">30976076</ArticleId></ArticleIdList></Reference><Reference><Citation>Medana IM, and Esiri MM (2003). Axonal damage: A key predictor of outcome in human CNS diseases. Brain 126, 515&#x2013;530. 10.1093/brain/awg061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awg061</ArticleId><ArticleId IdType="pubmed">12566274</ArticleId></ArticleIdList></Reference><Reference><Citation>Carty M, Kearney J, Shanahan KA, Hams E, Sugisawa R, Connolly D, Doran CG, Mu&#xf1;oz-Wolf N, G&#xfc;rtler C, Fitzgerald KA, et al. (2019). Cell Survival and Cytokine Release after Inflammasome Activation Is Regulated by the Toll-IL-1R Protein SARM. Immunity 50, 1412&#x2013;1424.e6. 10.1016/j.immuni.2019.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.04.005</ArticleId><ArticleId IdType="pubmed">31076360</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Li S, Qi J, Chen Z, Wu Y, Guo J, Wang K, Sun X, and Zheng J (2019). Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells. Cell Death Dis 10. 10.1038/s41419-019-1441-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1441-4</ArticleId><ArticleId IdType="pmc">PMC6389936</ArticleId><ArticleId IdType="pubmed">30804337</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zhang H, Li D, Zhou X, Qin Q, and Zhang Q (2021). Caspase-3-mediated GSDME induced Pyroptosis in breast cancer cells through the ROS/JNK signalling pathway. J Cell Mol Med 25, 8159&#x2013;8168. 10.1111/jcmm.16574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16574</ArticleId><ArticleId IdType="pmc">PMC8419174</ArticleId><ArticleId IdType="pubmed">34369076</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Wu Z, Renier N, Simon DJ, Uryu K, Park DS, Greer PA, Tournier C, Davis RJ, and Tessier-Lavigne M (2015). Pathological axonal death through a Mapk cascade that triggers a local energy deficit. Cell 160, 161&#x2013;176. 10.1016/j.cell.2014.11.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.11.053</ArticleId><ArticleId IdType="pmc">PMC4306654</ArticleId><ArticleId IdType="pubmed">25594179</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SY, Lopez-Gonzalez R, Krishnan G, Phillips HL, Li AN, Seeley WW, Yao WD, Almeida S, and Gao FB (2019). C9ORF72-ALS/FTD-associated poly(GR) binds Atp5a1 and compromises mitochondrial function in vivo. Nat Neurosci 22, 851&#x2013;862. 10.1038/s41593-019-0397-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0397-0</ArticleId><ArticleId IdType="pmc">PMC6800116</ArticleId><ArticleId IdType="pubmed">31086314</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan G, Huang C, Chen J, Chen B, and Zhi F (2021). Gasdermin-E-mediated pyroptosis participates in the pathogenesis of Crohn&#x2019;s disease by promoting intestinal inflammation. Cell Rep 35. 10.1016/j.celrep.2021.109265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109265</ArticleId><ArticleId IdType="pubmed">34133932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, and Shao F (2017). Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547, 99&#x2013;103. 10.1038/nature22393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22393</ArticleId><ArticleId IdType="pubmed">28459430</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, Li S, Wang B, Nemmara V. v, Wilson R, Jiang Z, Khalighinejad F, Muneeruddin K, et al. (2020). Succination inactivates gasdermin D and blocks pyroptosis. Science 369, 1633&#x2013;1637. 10.1126/science.abb9818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb9818</ArticleId><ArticleId IdType="pmc">PMC8744141</ArticleId><ArticleId IdType="pubmed">32820063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, Ruan J, Luo X, Lou X, Bai Y, et al. (2020). FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol 21, 736&#x2013;745. 10.1038/s41590-020-0669-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0669-6</ArticleId><ArticleId IdType="pmc">PMC7316630</ArticleId><ArticleId IdType="pubmed">32367036</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Pak CH, Han Y, Ahlenius H, Zhang Z, Chanda S, Marro S, Patzke C, Acuna C, Covy J, et al. (2013). Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785&#x2013;798. 10.1016/j.neuron.2013.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.05.029</ArticleId><ArticleId IdType="pmc">PMC3751803</ArticleId><ArticleId IdType="pubmed">23764284</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliuca FW, Millman JR, G&#xfc;rtler M, Segel M, Van Dervort A, Ryu JH, Peterson QP, Greiner D, and Melton DA (2014). Generation of Functional Human Pancreatic &#x3b2; Cells In Vitro. Cell 159, 428&#x2013;439. 10.1016/j.cell.2014.09.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.09.040</ArticleId><ArticleId IdType="pmc">PMC4617632</ArticleId><ArticleId IdType="pubmed">25303535</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SSW, Kiskinis E, Winborn B, Freibaum BD, Kanagaraj A, et al. (2014). Axonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations. Neuron 81, 536&#x2013;543. 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y, C&#xf4;me J, Piskorowski RA, Salah-Mohellibi N, Chevaleyre V, Peschanski M, Martinat C, and Nedelec S (2015). Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat Biotechnol 33, 89&#x2013;96. 10.1038/nbt.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3049</ArticleId><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang NJ, Isensee J, Neel D. v, Quadros AU, Zhang H-XB, Lauzadis J, Liu SM, Shiers S, Belu A, Palan S, et al. (2021). Anthrax toxins regulate pain signaling and can deliver molecular cargoes into ANTXR2+ DRG sensory neurons. Nat Neurosci. 10.1038/s41593-021-00973-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00973-8</ArticleId><ArticleId IdType="pmc">PMC9388775</ArticleId><ArticleId IdType="pubmed">34931070</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu H, Pekkurnaz G, Falk J, Wei W, Chin M, Steen J, and Schwarz TL (2021). FHL2 anchors mitochondria to actin and adapts mitochondrial dynamics to glucose supply. J Cell Biol 220. 10.1083/jcb.201912077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201912077</ArticleId><ArticleId IdType="pmc">PMC8340551</ArticleId><ArticleId IdType="pubmed">34342639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim Y, Kehm VM, Li C, Trojanowski JQ, and Lee VMY (2010). Forebrain overexpression of &#x3b1;-synuclein leads to early postnatal hippocampal neuron loss and synaptic disruption. Exp Neurol 221, 86&#x2013;97. 10.1016/j.expneurol.2009.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2009.10.005</ArticleId><ArticleId IdType="pmc">PMC2812632</ArticleId><ArticleId IdType="pubmed">19833127</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, et al. (2010). Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069&#x2013;1075. 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>